Hydrazide-based HDAC1/2/3 inhibitor decreases liver fibrosis in mouse models
June 19, 2024
The search for an effective therapy for liver fibrosis continues. A recent study by researchers at Medical University of South Carolina and collaborators explored the potential of a new compound, LP-340, as a treatment for liver fibrosis.